On August 11, the Appellate Division issued an important ruling in the ongoing litigation over Hoffmann-La Roche Ltd.’s acne medication Accutane. The decision by appellate judges Sabatino, Simonelli, and Leone overturns a $25 million+ verdict from a 2010 jury trial, and brings to a close a case that has been bogging down the court system for over a decade. It also sends a clear message that some choice of law questions are no longer open for debate.
This morning the Appellate Division issued an important ruling in the ongoing litigation over Hoffmann-La Roche Ltd.’s acne medication Accutane. The ruling brings to a close a case that has been bogging down the court system for over a decade, and sends a clear message that some choice of law questions are no longer open for debate.
This week the American Bar Association is holding its annual meeting in Chicago. Thanks to NJCJI and other pro-defense attorneys and organizations the ABA will not be voting on a controversial resolution (link) that would have put the ABA on record as “oppos[ing] legislation that limits and/or bans punitive damages for claims of patient harm allegedly caused by manufacturers of FDA-approved medical products or devices.”
A selection of the need-to-know civil justice news for the week of June 13-19.
A selection of the need-to-know civil justice news for the week of May 9-15.
Have you ever purchased Tylenol? If so, you are a potential member of a ridiculous class action lawsuit that has been filed against Johnson & Johnson.
For over a century, Americans have relied on the federal Food and Drug Administration (FDA) to regulate the quality and safety of everything from pharmaceutical products and medical devices to the labels on prepared foods. However, there is a growing trend in the courts that would allow lawsuits over these FDA approved items and their labels, effectively subjecting them to ad hoc regulation at the state level via litigation. On February 10, 2015, the New Jersey Civil Justice Institute hosted a panel discussion on this constantly evolving and critically important area of law with former Solicitor General Paul Clement of Bancroft PLLC; Gerald Masoudi of Covington & Burling LLP, who is the former Chief Counsel of the FDA; and Andrew Boczkowski, an Assistant General Counsel at GlaxoSmithKline.
A selection of the need-to-know civil justice news for the [...]
For many years, New Jersey has been called out in [...]
A selection of the need-to-know civil justice news for the [...]
